Evaluation of Healthcare Workers Safety During Pressurized Intraperitoneal Aerosol Chemotherapy
NCT04014426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2019-07-10
Summary
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment that applies chemotherapeutic drugs into the peritoneal cavity as an aerosol. It is used to treat patient with Peritoneal Carcinomatosis (PC). During this procedure, healthcare workers may be under risks of exposure to cytotoxic treatments.
The purpose of this study is to evaluate the safety of the heathcare workers and the risk of operation room Oxaliplatin's contamination during a PIPAC.
Conditions
- Safety
- Healthy Volunteers
Interventions
- OTHER
-
Blood sample
Exposed group: * 15 to 30 minutes before the start of the procedure: 1 EDTA tube of 6 ml for blood (T0) * 2hours after the end of the procedure: 1 EDTA tube of 6 ml (T1) Non-exposed group: \- During the morning (8 to 10 a.m): 1 EDTA tube of 6 ml (T0)
- OTHER
-
Urinary sample
Exposed group: * 15 to 30 min before the PIPAC procedure (T0) * 2hours after the end of the procedure (T1) * The next morning after the procedure (T2) Non-exposed group: \- During the morning (8 to 10 a.m) (T0)
Sponsors & Collaborators
-
Institut du Cancer de Montpellier - Val d'Aurelle
lead OTHER
Principal Investigators
-
Olivia SGARBURA, MD · ICM - Institut régional du Cancer Montpellier
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-02
- Primary Completion
- 2018-07-04
- Completion
- 2018-07-04
Countries
- France
Study Locations
More Related Trials
-
Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy in Patients With Peritoneal Carcinoma.
NCT04779385 ·Status: COMPLETED
-
Treating Peritoneal Carcinomatosis With PIPAC
NCT02320448 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma
NCT02217956 ·Status: COMPLETED ·Phase: PHASE1
-
Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer
NCT01809379 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer
NCT00919984 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT01219777 ·Status: COMPLETED ·Phase: PHASE1
-
Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
NCT01680575 ·Status: UNKNOWN
-
Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer
NCT04885270 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
NCT00421889 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
NCT01650376 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
NCT02001272 ·Status: COMPLETED ·Phase: PHASE2
-
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
NCT00807768 ·Status: UNKNOWN ·Phase: PHASE3
-
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
NCT00005046 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
NCT01461746 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -
NCT03287375 ·Status: COMPLETED ·Phase: PHASE2
-
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
NCT00112086 ·Status: COMPLETED ·Phase: PHASE2
-
PIPAC for Peritoneal Metastases
NCT04956068 ·Status: SUSPENDED ·Phase: PHASE1
-
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
NCT05415709 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
NCT02112552 ·Status: TERMINATED ·Phase: PHASE2
-
Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis
NCT02866903 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol
NCT02501954 ·Status: COMPLETED ·Phase: PHASE3
-
Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer
NCT02681432 ·Status: UNKNOWN ·Phase: PHASE3
-
Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)
NCT05056389 ·Status: UNKNOWN ·Phase: PHASE1
-
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer
NCT03189446 ·Status: COMPLETED ·Phase: PHASE2
-
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer
NCT04282356 ·Status: RECRUITING ·Phase: PHASE2